LNTH Q1 2020 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q1 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$91M+4.8% YoY

Gross Profit

$38M41.9% margin

Operating Income

$7M7.9% margin

Net Income

$3M3.7% margin

EPS (Diluted)

$0.08

QoQ Revenue Growth

+1.5%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$404M

Total Liabilities

$286M

Stockholders' Equity

$118M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$91M	$87M	+4.8%
Gross Profit	$38M	$44M	-13.8%
Operating Income	$7M	$16M	-55.9%
Net Income	$3M	$10M	-66.5%

Revenue Segments

DEFINITY

$57M71%

Techne Lite

$23M29%